TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
FATE

Fate Therapeutics Inc

Healthcare · Biotechnology

2.50$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Fate Therapeutics Inc (FATE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 319 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FATE
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
51 68 95 105 213 302 622 921 706 506 441 319
50 66 93 103 205 227 494 633 502 332 292 209
49 65 89 89 191 100 167 134 61 42 36 47
49 65 92 101 201 221 483 616 436 315 279 204
0.5 1.3 5.5 8.7 38 1.8 3.5 0.9
0.0 0.0 0.0 0.0 0.0 0.0 0.0
1.2 2.2 1.6 2.6 5.1 11 32 162 176
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
23 30 22 28 53 58 238 243 222 138 122 112
4.6 13 15 11 27 28 86 81 114 39 39 36
1.5 6.6 8.2 7.3 2.4 1.7 3.4 5.6 5.6 6.2 7.4 4.6
0.6 1.0 0.9 1.7 4.2 5.8 6.3 8.6 8.3 4.7 9.4 2.7
18 11 2.5 15 12
28 38 73 77 160 245 384 679 484 368 319 207
-112 -142 -176 -219 -285 -384 -557 -769 -1,051 -1,212 -1,398 -1,534
20 25 32 42 56 68 82 95 97 98 114 119

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?